Stéphanie Struski

2.4k total citations
30 papers, 596 citations indexed

About

Stéphanie Struski is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Stéphanie Struski has authored 30 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 12 papers in Genetics and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Stéphanie Struski's work include Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Stéphanie Struski is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Acute Lymphoblastic Leukemia research (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Stéphanie Struski collaborates with scholars based in France, Belgium and Austria. Stéphanie Struski's co-authors include Pascale Cornillet‐Lefèbvre, Martine Doco‐Fenzy, Éric Delabesse, Michel Lessard, Nicole Dastugue, Éric Lippert, Vincent Leymarie, Cyril Broccardo, Christian Bastard and Carine Gervais and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Stéphanie Struski

30 papers receiving 590 citations

Peers

Stéphanie Struski
Bashar Dabbas United States
T Flores Spain
Lan‐Lan Smith United Kingdom
Gordon W. Dewald United States
Stéphanie Struski
Citations per year, relative to Stéphanie Struski Stéphanie Struski (= 1×) peers Françoise Brizard

Countries citing papers authored by Stéphanie Struski

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Struski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Struski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Struski more than expected).

Fields of papers citing papers by Stéphanie Struski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Struski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Struski. The network helps show where Stéphanie Struski may publish in the future.

Co-authorship network of co-authors of Stéphanie Struski

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Struski. A scholar is included among the top collaborators of Stéphanie Struski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Struski. Stéphanie Struski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Péricart, Sarah, Aurore Siegfried, Stéphanie Struski, et al.. (2019). Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor—a case report and review of literature. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(4). 609–614. 18 indexed citations
2.
Nguyen‐Khac, Florence, Claire Borie, Evelyne Callet‐Bauchu, Virginie Éclache, & Stéphanie Struski. (2016). Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH). Annales de biologie clinique. 74(5). 561–567. 3 indexed citations
3.
Ballerini, Paola, Stéphanie Struski, Naïs Prade, et al.. (2012). RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation. Leukemia. 26(11). 2384–2389. 81 indexed citations
4.
Gross, Emilie, Loïc Ysebaert, Stéphanie Struski, et al.. (2010). B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells. Leukemia. 24(11). 1885–1892. 15 indexed citations
5.
Nguyen‐Khac, Florence, Claude Lesty, Virginie Éclache, et al.. (2010). Chromosomal abnormalities in transformed Ph‐negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations. Genes Chromosomes and Cancer. 49(10). 919–927. 15 indexed citations
6.
Nguyen‐Khac, Florence, Lucile Couronné, Virginie Éclache, et al.. (2009). Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.. Blood. 114(22). 2900–2900. 1 indexed citations
7.
Weer, An De, Frank Speleman, Barbara Cauwelier, et al.. (2008). EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22. Haematologica. 93(12). 1903–1907. 19 indexed citations
8.
Struski, Stéphanie, Catherine Hélias, Carine Gervais, et al.. (2007). Confirmation of a novel recurrent association: BCR-ABL t(9;22) and t(19;21). Cancer Genetics and Cytogenetics. 179(2). 127–131. 3 indexed citations
9.
Hélias, Catherine, Stéphanie Struski, Carine Gervais, et al.. (2007). Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2. Cancer Genetics and Cytogenetics. 180(1). 51–55. 25 indexed citations
10.
Struski, Stéphanie, Catherine Hélias, Carine Gervais, et al.. (2007). 13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation. Cancer Genetics and Cytogenetics. 174(2). 151–160. 8 indexed citations
11.
Hélias, Catherine, Cécile Fohrer, Stéphanie Struski, et al.. (2006). Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH. Cancer Genetics and Cytogenetics. 168(2). 133–145. 15 indexed citations
12.
Struski, Stéphanie, Vincent Leymarie, Catherine Hélias, et al.. (2006). Étude cytologique, immunophénotypique et cytogénétique d'une série de 136 cas consécutifs d'hémopathies lymphoïdes chroniques à cellules B matures. Pathologie Biologie. 55(1). 59–72. 2 indexed citations
13.
Chapiro, Élise, Lisa J. Russell, Christian Bastard, et al.. (2006). Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood. 108(10). 3560–3563. 48 indexed citations
14.
Bednarek, Nathalie, Stéphanie Struski, Juliette Albuisson, et al.. (2006). Pure direct duplication (12)(q24.1 → q24.2) in a child with Marcus Gunn phenomenon and multiple congenital anomalies. American Journal of Medical Genetics Part A. 140A(3). 212–221. 28 indexed citations
15.
Lessard, M, Stéphanie Struski, Vincent Leymarie, et al.. (2005). Cytogenetic study of 75 erythroleukemias. Cancer Genetics and Cytogenetics. 163(2). 113–122. 31 indexed citations
16.
Lessard, M, Carine Gervais, & Stéphanie Struski. (2003). Anomalies cytogénétiques des syndromes myélodysplasiques et leucoses aiguës secondaires. Pathologie Biologie. 51(6). 356–365. 2 indexed citations
17.
Struski, Stéphanie, Martine Doco‐Fenzy, Michael Köehler, et al.. (2003). Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity. Analytical Cellular Pathology. 25(3). 115–122. 3 indexed citations
18.
Struski, Stéphanie, Martine Doco‐Fenzy, & Pascale Cornillet‐Lefèbvre. (2002). Compilation of published comparative genomic hybridization studies. Cancer Genetics and Cytogenetics. 135(1). 63–90. 104 indexed citations
19.
Struski, Stéphanie, et al.. (2002). Cytogenetic characterization of chromosomal rearrangement in a human vinblastine-resistant CEM cell line. Cancer Genetics and Cytogenetics. 132(1). 51–54. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026